July 24, 2023

Daily Statin Reduces Heart Disease Risk Among Adults Living With HIV

July 24, 2023 — A National Institute of Health-supported study found that statins, a class of cholesterol-lowering medications, may offset

Become an Independent Clinical Investigator: Participant Perspectives

Listen to past participants discuss why they chose the Global Clinical Scholars Research Training Program.

Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

In this article JNJ Follow your favorite stocksCREATE FREE ACCOUNT Kenvue, a unit of Johnson & Johnson’s consumer health business.

Breastfeeding linked to reduced post-perinatal infant mortality

Among nearly 10 million US infants born between 2016 and 2018, breastfed babies were 33% less likely to die during

Young Man’s Claw-Like Hands and Annular, Reddened Skin Plaques

A previously healthy young man in his 20s developed ring-like lesions on his torso and other areas of his body

Customers of xNARA Report 98% success – The Truth Behind its Product

MarketsandMarkets estimates that, in the US, dietary supplements will claim a $167.5 billion market in 2023. Over half of American

Rheumatology Summit Tackles Race Disparities in Lupus Trials

Clinical research in lupus has a mammoth diversity problem: Black individuals are most likely to develop the disease, but they’re

Bipolar Patients 6 Times More At Risk Of Early Death From External Causes: Study

Patients with bipolar disorder have a heightened risk of early death. However, the particular drivers that contribute to the increased

After Norgestrel, Which Other Drugs Should Go OTC?

Earlier this month, the US Food and Drug Administration approved the first over-the-counter (OTC) norgestrel birth control pill (Opill). The

-